Skip to main content
Sign In

About the Program

                        Thomas L. Petty Aspen Lung Conference
                                      60th Annual Meeting 

        ‘’Environment and Global Lung Health: Exposure, Susceptibility and Intervention”                                        L​isa A. Maier, M.D., M.S.P.H. Chair
           Arnold R. Brody, Ph.D. and David A. Schwartz, M.D., M.P.H., Co-Chairs                                                 June 7-10, 2017                                                                            The Gant Conference Center                                                                                                                   Aspen, Colorado

The majority of chronic lung diseases are due to environmental exposures, and occupational toxicants.  Understanding the mechanisms by which exposures cause chronic lung diseases, and developing novel strategies to limit or prevent these diseases would significantly impact global lung health. With an emphasis on the integration of basic, translational and clinical approaches, the 60th Annual Thomas L. Petty Aspen Lung Conference will focus on a central question: how can knowledge of the mechanisms underlying exposure-induced chronic lung diseases be translated into effective approaches to treat and ultimately prevent disease burden? To address this central question, we organized the program into a series of thematic sessions focusing on (i) the magnitude and burden of exposure-induced lung diseases and their impact on global health (ii) exposure assessment, exposure biology and the susceptible host, (iii) the molecular mechanisms of exposure that result in lung fibrosis, asthma and other chronic lung diseases, (iv) epigenetic, genetic, and genomic interactions with the environment, resulting in obstructive lung disease, cancer, and pulmonary fibrosis and (v) strategic approaches to translate scientific advances to prevent and intervene to reduce exposures and improve lung health. These diverse themes will be reconciled in a concluding Conference Summary presented by Jonathan M. Samet, M.D., M.S., Professor of Preventive Medicine and Director, Institute for Global Health, University of Southern California.

Abstract deadline is February 14, 2017.  For more information, contact: Lisa A. Maier, M.D., c/o Jeanne Cleary, Thomas L. Petty Aspen Lung Conference, PO Box 1622, Parker, CO 80134   Phone:  (303) 358-2797.  Fax:  (720) 851-1034. 


We seek to accomplish the following objectives:

1.        To provide an international forum for leading basic, translational, and clinical researchers to exchange ideas regarding fundamental concepts regarding the contribution of exposure and susceptibility to development of chronic lung disease.

2.        To stimulate interactions between the scientific fields of exposure biology, molecular biology, epigenetics, genetics, genomics and public health with the goal of identifying emerging, shared interests that may lead to the performance of more efficient and productive research.

3.        To enhance the likelihood of success in translation of preclinical scientific advances into direct patient benefit by developing novel strategies to better implement scientific advances approaches to intervene to reduce disease progression and exposures, and enhance lung health globally.

4.        To challenge and stimulate the scientific interests of trainees, attracting a new generation of junior investigators into the field of exposure-induced lung disease and global health.


At the conclusion of this conference attendees will be able to:

1)      Discuss state-of-the-art concepts regarding the contribution of exposure and host susceptibility to chronic lung disease, including common diseases such as COPD, asthma, interstitial lung diseases and cancer.

2)      Appreciate the complex interactions between exposure, molecular mechanisms of exposure, as well as epigenetic, genetic and genomics mechanisms in the pathology of exposure-induced lung disease.

3)      Incorporate concepts from the growing fields of exposure biology and exposure assessment, stem cell biology, Omics, including epigenetics and transcriptomic, into experimental approaches to better define the mechanisms of exposure induced lung pathobiology.

4)    To develop novel strategies to reduce exposures and enhance lung health and prevent disease.


 Intended Audience:  Local/Regional/National/International

Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists-Environmental Lung Health, Pulmonary Sciences, Critical Care and Sleep Medicine/Primary Care Physicians/General Medicine Physicians/Public Health.​

AMEricans with Disability Act statement 
Please indicate if you have any need for auxiliary aids or special assistance services